Imricor Medical Systems - Public Comps and Valuation Multiples

Imricor Medical Systems Overview

About Imricor Medical Systems

Imricor Medical Systems Inc is a medical device company that develops MRI-guided technology to address issues with traditional X-ray ablation procedures. Its principal business activities are designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The company's products include the Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter, and Vision-MR Dispersive Electrode. Geographically, the company generates maximum revenue from Europe, followed by the Middle East and the United States.

Founded

2006

HQ

Employees

n/a

Website

imricor.com

Sectors

Medical Devices
DeepTech
HealthTech

Financials

LTM Revenue $1.7M

LTM EBITDA -$30.2M

EV

$280M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Imricor Medical Systems Financials

As of September 2025, Imricor Medical Systems reported last 12-month revenue of $1.7M and EBITDA of -$30.2M.

In the same period, Imricor Medical Systems achieved -$38.3M in LTM net income.

See Imricor Medical Systems valuation multiples based on analyst estimates

Imricor Medical Systems P&L

In the most recent fiscal year, Imricor Medical Systems reported revenue of $0.6M and EBITDA of -$18.8M.

Imricor Medical Systems expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Imricor Medical Systems valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$1.7M	XXX	$0.6M	XXX	XXX	XXX
Gross Profit	n/a	XXX	-$0.6M	XXX	XXX	XXX
Gross Margin	n/a	XXX	-96%	XXX	XXX	XXX
EBITDA	-$30.2M	XXX	-$18.8M	XXX	XXX	XXX
EBITDA Margin	-1817%	XXX	-3015%	XXX	XXX	XXX
EBIT	-$31.0M	XXX	-$11.1M	XXX	XXX	XXX
EBIT Margin	-1860%	XXX	-1779%	XXX	XXX	XXX
Net Profit	-$38.3M	XXX	-$19.3M	XXX	XXX	XXX
Net Margin	-2301%	XXX	-3095%	XXX	XXX	XXX
Net Debt	XXX	XXX	$2.9M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Imricor Medical Systems including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $1.7M. EBITDA for the last twelve months was -$30.2M. In the most recent fiscal year, Imricor Medical Systems achieved $0.6M in revenue and -$18.8M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$1.7M	Analyst estimates available to subscribers	$0.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	-$0.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	-96.3% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	-$30.2M	Analyst estimates available to subscribers	-$18.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	-1817.0% EBITDA margin	Analyst estimates available to subscribers	-3014.8% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$31.0M	Analyst estimates available to subscribers	-$11.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-1860.2% EBIT margin	Analyst estimates available to subscribers	-1778.5% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$38.3M	Analyst estimates available to subscribers	-$19.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-2301.3% net profit margin	Analyst estimates available to subscribers	-3094.9% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$2.9M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Imricor Medical Systems

This financial data table provides comprehensive performance metrics for Imricor Medical Systems, a company based in Australia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Imricor Medical Systems generated $1.7M in revenue over the last twelve months.
The company achieved -$30.2M in EBITDA over the last twelve months.
Net income over the last twelve months reached -$38.3M.

Fiscal Year Performance

In the most recent fiscal year, Imricor Medical Systems reported $0.6M in total revenue.
Fiscal year EBITDA was -$18.8M.
The company maintained a gross profit margin of -96.3% in the most recent fiscal year.
EBITDA margin for the fiscal year was -3014.8%.
Net profit margin reached -3094.9% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Imricor Medical Systems. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Imricor Medical Systems Stock Performance

Imricor Medical Systems has current market cap of AUD 462M (or $300M), and EV of AUD 430M (or $280M).

Market Cap Evolution

Imricor Medical Systems Stock Data

As of October 27, 2025, Imricor Medical Systems's stock price is AUD 1 (or $1).

See Imricor Medical Systems trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$280M	$300M	XXX	XXX	XXX	XXX	$-0.35

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Imricor Medical Systems Valuation Multiples

Imricor Medical Systems's trades at 448.2x EV/Revenue multiple, and -14.9x EV/EBITDA.

See valuation multiples for Imricor Medical Systems and 15K+ public comps

Imricor Medical Systems Financial Valuation Multiples

As of October 27, 2025, Imricor Medical Systems has market cap of $300M and EV of $280M.

Equity research analysts estimate Imricor Medical Systems's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Imricor Medical Systems has a P/E ratio of -12.1x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$300M	XXX	$300M	XXX	XXX	XXX
EV (current)	$280M	XXX	$280M	XXX	XXX	XXX
EV/Revenue	258.4x	XXX	448.2x	XXX	XXX	XXX
EV/EBITDA	-14.2x	XXX	-14.9x	XXX	XXX	XXX
EV/EBIT	-13.9x	XXX	-25.2x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	-12.1x	XXX	-15.6x	XXX	XXX	XXX
EV/FCF	-15.9x	XXX	-27.5x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Imricor Medical Systems Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Imricor Medical Systems Margins & Growth Rates

Imricor Medical Systems's last 12 month revenue growth is 313%

Imricor Medical Systems's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Imricor Medical Systems's rule of 40 is -3240% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Imricor Medical Systems's rule of X is -1034% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Imricor Medical Systems and other 15K+ public comps

Imricor Medical Systems Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	313%	XXX	189%	XXX	XXX	XXX
EBITDA Margin	-1817%	XXX	-3015%	XXX	XXX	XXX
EBITDA Growth	-3%	XXX	n/a	XXX	XXX	XXX
Rule of 40	-3240%	XXX	-2702%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	-1034%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	237%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	853%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	1682%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial